Exploration of Targeted Anti-tumor Therapy

An open access journal, indexed in PubMed/PMC & Scopus, Google Scholar, DOAJ, CAS, etc. CiteScore Tracker: 5.2
Editorial Office: [email protected]

[Exploration of Targeted Anti-tumor Therapy @ETAT_journal]

📢Publish in #ETAT about #OriginalArticle!
📷Title: CHD4 and NOX4 expression in thyroid tumor tissues
https://t.co/QUN9LWGJOW
#OpenAccess #CancerResearch #Tumor #Oncology #AcademicPublishing #CancerTreatment #PrecisionMedicine

[Exploration of Targeted Anti-tumor Therapy @ETAT_journal]

🏆 We are pleased to announce the winner of the ETAT Highly Cited Paper Award!

📄 Novel therapeutic strategies targeting myeloid-derived suppressor cell immunosuppressive mechanisms for cancer treatment

🔗https://t.co/AgTcvc6PMF

#Oncology #HighlyCitedPaper #OpenAccess #Scopus

[Exploration of Targeted Anti-tumor Therapy @ETAT_journal]

📣 Welcome Prof. Raffaele Capasso to the Editorial Board of Exploration of Targeted Anti-tumor Therapy! 📷 His research interests: #ColonCancer; #MedicinalPlants; #inflammation; #nutraceutical; #microbiot; #IntestinalMotility
📷https://t.co/YGtCm7ltfK

[Exploration of Targeted Anti-tumor Therapy @ETAT_journal]

📣 Welcome Prof. Uday Kishore to the Editorial Board of Exploration of Targeted Anti-tumor Therapy!
📚 His research interests: #PancreaticCancer; #glioblastoma;#BreastCancer; #InnateImmunity; #complement;#SurfactantProtein
🔗 More Board Members of ETAT: https://t.co/BL2Jm0zYz1

[Exploration of Targeted Anti-tumor Therapy @ETAT_journal]

📢Publish in #ETAT about #Review!
📷Title: Smart nanofluidic systems powered by DNA origami for targeted intracellular delivery: a newer approach
https://t.co/iJuUtrHTiK

[Exploration of Targeted Anti-tumor Therapy @ETAT_journal]

📢Publish in #ETAT about #CaseReport!
📷Title: Immune checkpoint inhibitor-induced hemophagocytic lymphohistiocytosis in lung cancer: a case series
https://t.co/YsrFVmFrPZ

[Exploration of Targeted Anti-tumor Therapy @ETAT_journal]

🧬ETAT New #CaseReport Alert!
📷Sharing the latest publication:
https://t.co/YsrFVmFrPZ
#CancerTreatment #Oncology #APCdiscount #OpenAccess

[Exploration of Targeted Anti-tumor Therapy @ETAT_journal]

🧬ETAT New #Review Alert!
📷Sharing the latest publication:
📷Read more: https://t.co/xL0nK9XZVz
#CancerTreatment #Oncology #APCdiscount #OpenAccess

[Exploration of Targeted Anti-tumor Therapy @ETAT_journal]

🧬ETAT New #OriginalArticle Alert!
👏Sharing the latest publication:
✍️ Racial disparities in hepatocellular carcinoma: a TCGA-based gene expression study of Caucasian and Asian populations
👏Read more:
https://t.co/sf8ob2iuuz
#CancerTreatment #Oncology #APCdiscount #OpenAccess

[Exploration of Targeted Anti-tumor Therapy @ETAT_journal]

🧬ETAT New #Review Alert!
👏Sharing the latest publication:
✍️ New approaches of green silver #nanoparticles for cancer and biomedical applications: a review
👏Read more:
https://t.co/k8LLU64W9d
#CancerTreatment #Oncology #APCdiscount #OpenAccess

[Exploration of Targeted Anti-tumor Therapy @ETAT_journal]

🧬ETAT New #OriginalArticle Alert!
👏Sharing the latest publication:
✍️ Synergistic anticancer efficacy of optimized curcumin-piperine loaded magnetic #nanoparticles for the treatment of colorectal cancer
👏Read more:
https://t.co/Tm1XDBg6HK
#CancerTreatment #Oncology

[Exploration of Targeted Anti-tumor Therapy @ETAT_journal]

🧬ETAT New #Review Alert!
👏Sharing the latest publication:
✍️ Engineered nanocarriers for targeted lung cancer therapy: mechanistic innovations and recent clinical progress
👏Read more: https://t.co/mW7UjJlWuW
#CancerTreatment #Oncology #PrecisionMedicine

[Exploration of Targeted Anti-tumor Therapy @ETAT_journal]

📢We announce a special issue on Breaking Boundaries in Breast Cancer Care: Emerging Controversies and Innovation in Surgical and Medical Approaches.
✍ Guest Editor: Dr. Armando Orlandi
🔗About the Special Issue: https://t.co/pZqjDbxEm6

[Exploration of Targeted Anti-tumor Therapy @ETAT_journal]

📢 We are thrilled to share the latest articles published in August:
📖 All articles are open access, welcome to read, download, and share!
https://t.co/nCxW5Mo1zM
�� We welcome submissions of high-quality research! Join us in advancing scientific discourse

[Exploration of Targeted Anti-tumor Therapy @ETAT_journal]

🧬ETAT New #Review Alert!
👏Sharing the latest publication:
✍️Genetic and epigenetic landscape of O6-methylguanine-DNA methyltransferase (#MGMT): implications for DNA repair and cancer therapeutics
Read more: https://t.co/4xCE1Y9Qo9
#CancerTreatment #Oncology #PrecisionMedicine

[Exploration of Targeted Anti-tumor Therapy @ETAT_journal]

🧬 ETAT New #Review Alert!
👏Sharing the latest publication:
Inflammatory signatures across four photon radiotherapy and proton radiotherapy: mechanisms, mitigation, and quality of life impact
📖 Read more: https://t.co/kmrMTdwtLg
#CancerTreatment #Oncology #PrecisionMedicine

[Exploration of Targeted Anti-tumor Therapy @ETAT_journal]

📣Call for Guest Editor
We're inviting researchers to serve as Guest Editor for Special Issue in our journal.
📥If you're interested in leading a Special Issue, feel free to leave a message.
🤝Let's collaborate to bring topic to the forefront of research!
https://t.co/HRnMRI8OjM

[Exploration of Targeted Anti-tumor Therapy @ETAT_journal]

🧬 New #CitedPaper Alert!
👏We're excited to share the latest publication:
"Dysbiosis and #ColorectalCancer: conducive factors, biological and molecular role, and therapeutic prospectives"
📖 Read more: https://t.co/gnTX1ecBfK
#CancerTreatment #Tumor #Oncology #PrecisionMedicine

[Exploration of Targeted Anti-tumor Therapy @ETAT_journal]

🧬 New #Review Alert!
We're excited to share the latest publication:
" Improvement of the sensitivity of circulating tumor DNA-based #LiquidBiopsy: current approaches and future perspectives "
🔗 Full article: https://t.co/mSBjo0s0Wi

[Exploration of Targeted Anti-tumor Therapy @ETAT_journal]

🧬 New #OriginalArticle Alert!
We're excited to share the latest publication:
" Anti-angiogenic effects of Moringa oleifera silver #nanoparticles on endothelial cells: in vitro and ex vivo studies "
🔗 Full article: https://t.co/SVZEiR6wXP